Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04044469
Other study ID # ROMA_199
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 23, 2019
Est. completion date December 23, 2021

Study information

Verified date January 2022
Source Philipps University Marburg Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Research has shown that patients with functional somatic symptoms continue to worry about having a serious disease despite medical reassurance from their doctors. This study aims to investigate whether cognitive immunization is a mechanism that underlies the sustained concern about having serious disease. To this end, the use of cognitive immunization strategies will be experimentally modulated after receipt of medical test results.


Description:

It is known from research on functional somatic symptoms that patients continue to worry about having a serious illness despite receiving medical reassurance and normal medical test results. However, the psychological mechanisms underlying this maintenance of concern are largely unknown. The planned study will therefore apply knowledge from depression research to this question: In the field of depression there is sound evidence that people with depressive symptoms maintain negative expectations despite positive experiences to the contrary, and in previous work it was shown that this is due to a cognitive re-appraisal of expectation-disconfirming experiences, referred to as cognitive immunization. The planned study seeks to investigate whether cognitive immunization is also a mechanism underlying sustained concerns about having a serious disease despite medical reassurance in patients with functional somatic symptoms. For this purpose, participants are presented with a vignette in which gastrointestinal complaints are reported; participants are instructed to imagine to suffer from these symptoms and to go a doctor to have their symptoms examined. Subsequently, participants watch a videotaped doctor's report in which a family doctor discusses the results of several medical tests that have been carried out to exclude the possibility of some serious diseases, such as colon cancer. In this report, the doctor states clearly that, based on the test results, a serious disease is very unlikely. Afterwards, participants of some experimental groups receive additional information on the accuracy of medical diagnostics, aimed at differentially varying the appraisal of the medical reassurance received. The experimental conditions described above apply only to the sample of patients with functional somatic symptoms (inclusion and exclusion criteria see below). In addition, we will also recruit a clinical (patients with depression, n=30) and healthy control group (n=30). These control groups will not undergo the cognitive immunization manipulation, but will only pass through the basic procedure of the experimental paradigm, that is, the same procedure as the control group from the sample of patients with functional somatic symptoms. These two control groups (healthy and clinical) are recruited to replicate previous findings showing that patients with somatic symptoms report increased probabilities of suffering from a serious disease compared to patients with depression and healthy control participants. Below, we will only present the inclusion and exclusion criteria of the sample with functional somatic symptoms.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 23, 2021
Est. primary completion date December 23, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: - Primary diagnosis of a somatoform disorder (F45.x) (as assessed with the SKID interview) - Age between 18 and 69 - Sufficient German language skills Exclusion Criteria: - acute life-threatening disease - diagnosed mental disorder other than the somatoform disorder that is considered the primary diagnosis (people with other comorbid mental disorders are not excluded if the somatoform disorder is the primary diagnosis)

Study Design


Intervention

Behavioral:
Immunization-enhancement
This group receives a standardized information text, suggesting that medical diagnostics is not very accurate. Reasons for why a serious disease is overlooked are mentioned and discussed.
Immunization-inhibition
This group receives a standardized information text, suggesting that medical diagnostics is very accurate and that doctors are very often right in their first initial diagnostic assessments.
Control group
This group receives no further information after watching the videotaped doctor's report.

Locations

Country Name City State
Germany University of Koblenz-Landau Landau Rheinland-Pfalz

Sponsors (3)

Lead Sponsor Collaborator
Philipps University Marburg Medical Center Harvard Medical School (HMS and HSDM), University of Koblenz-Landau

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Likelihood of a serious disease scale Numerical analogue scale to assess the likelihood of having a serious disease (0 = serious disease excluded; 100 = serious disease for sure) 2 minutes after the doctor's report
Secondary Cognitive immunization against medical reassurance scale Assessment of cognitive reappraisal of medical reassurance; each item is scored 1-7 (1 = totally disagree; 7 = totally agree) 5 minutes after the doctor's report
See also
  Status Clinical Trial Phase
Completed NCT05446766 - Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety N/A
Completed NCT04122846 - Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder N/A
Completed NCT04511286 - Exposure-Based Treatment for Undifferentiated Somatic Symptom Disorder N/A
Active, not recruiting NCT06149182 - Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Patients With Functional Somatic Disorder N/A
Completed NCT04664387 - Somatic Symptom Disorders in Patients With Myocardial Bridge
Completed NCT01966705 - Cognitive Behavior Therapy for Health Anxiety: A Comparison of Three Forms of Self-help N/A
Enrolling by invitation NCT03789084 - Hybrid Trial of Brief Cognitive-Behavioral Therapy for Health Anxiety in Primary Care N/A
Recruiting NCT05666921 - Alexithymia and Attachment Style in Patients With Somatic Symptoms
Recruiting NCT04835103 - Build a Research Clinic for Somatoform Patients N/A
Completed NCT03986125 - Student Anxiety & Stress Study N/A
Recruiting NCT05946512 - MR-spectroscopy in Post-covid Condition Prior to and Following a Yoga Breathing Intervention N/A
Recruiting NCT05792930 - Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder N/A
Recruiting NCT04899687 - Study of Dextromethorphan in OCD and Related Disorders Phase 2
Completed NCT05886361 - Somatic Symptoms in Autism Spectrum Disorder: Data Integration
Completed NCT02131883 - Outcome of Cognitive Behavioral Therapy for Patients With Severe Health Anxiety Treated in Group Only. A RCT. N/A
Completed NCT04751825 - Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder - A Randomized Controlled Trial N/A
Completed NCT02314065 - Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy N/A
Recruiting NCT06301360 - Internet Based Emotional Awareness and Expression Therapy for Functional Somatic Disorder With and Without Therapist Support N/A
Recruiting NCT05161819 - Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder N/A
Completed NCT05795803 - Effects of COVID-19 Forced Isolation Context on Adolescents With and Without Somatic Symptom Disorder